NCT05467748 2026-01-27
EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer
VA Office of Research and Development
Phase 1/2 Recruiting
Clinical Trials
3 trialsNCT05430009 2022-08-01
Liver SBRT in Combination With Immune Checkpoint Inhibition in Patients With Metastatic Non-small Cell Lung Cancer
VA Ann Arbor Healthcare System
Phase 1 Recruiting
NCT03753243 2022-04-20
Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer
Portland VA Medical Center
Phase 2 Recruiting